Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 47, Issue 2, 2008, Pages 199-208

  Silva, Raul R ^a,e   Muniz, Rafael ^b   Pestreich, Linda ^b   Brams, Matthew ^c   Mao, Alice R ^c   Childress, Ann ^d   Wang, James ^b  

^a NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^b Novartis Pharmaceuticals

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Center for Psychiatry and Behavioral Medicine

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Attention deficit hyperactivity disorder; Dexmethylphenidate extended release; Pediatric

Indexed keywords

DEXMETHYLPHENIDATE; PLACEBO;

ABRASION; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATTENTION; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLICULITIS; GASTROENTERITIS; HEADACHE; HUMAN; LABORATORY TEST; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MULTICENTER STUDY; PHARYNGITIS; PRIORITY JOURNAL; PROTEINURIA; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINORRHEA; SCABIES; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TOOTH PAIN; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION;

EID: 38549125958     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/chi.0b013e31815cd9a4     Document Type: Article

References (18)

1. Goldman LS, Genel M, Bezman RJ, et al. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA. 1998;279:1100-1107.
2. Seidman LJ, Valera EM, Bush G. Brain function and structure in adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27:323-347.
3. Wilens TE, Biederman J. The stimulants. Psychiatr Clin North Am. 1992;15:191-222.
4. Quinn D, Wigal S, Swanson J, et al. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,lthreo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attentiondeficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004;43:1422-1429.
5. Srinivas NR, Hubbard JW, Quinn D, et al. Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder. Clin Pharmacol Ther. 1992;52:561-568.
6. Wigal S, Swanson JM, Feifel D, et al. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threomethylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004;43:1406-1414.
7. Swanson JM, Wigal SB, Wigal T, et al. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (Comacs Study). Pediatrics 2004;113:e206-e216.
8. Focalin XR package insert. Physicians' Desk Reference, 61st ed. Montvale, NJ: Thomson PDR; 2007:2223-2227.
9. Silva RR, Muniz R, Pestreich L, et al. Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006;16:239-251.
10. Lawrence V, Houghton S, Douglas G, et al. Executive function and ADHD: a comparison of children's performance during neuropsychological testing and real-world activities. J Atten Disord. 2004;7:137-149.
11. Lopez F, Silva R, Pestreich L, et al. Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day. Paediatr Drugs 2003;5:545-555.
12. Computerized Diagnostic Interview Schedule for Children, IV (NIMH CDISC IV). New York: Columbia University; 1997.
13. Wigal SB, Gupta S, Guinta D, et al. Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacol Bull. 1998;34:47-53.
14. Swanson JM, Wigal S, Greenhill LL, et al. Analog classroom assessment of Adderall in children with ADHD. J Am Acad Child Adolesc Psychiatry. 1998;37:519-526.
15. Swanson J, Castellanos FX, Murias M, et al. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol. 1998;8:263-271.
16. Swanson JM, Wigal SB, Udrea D, et al. Evaluation of individual subjects in the analog classroom setting: I. Examples of graphical and statistical procedures for within-subject ranking of responses to different delivery patterns of methylphenidate. Psychopharmacol Bull. 1998;34:825-832.
17. Kowalik S, Minami H, Silva R. Dexmethylphenidate extended-release capsules for the treatment of attention deficit hyperactivity disorder. Expert Opin Pharmacother. 2006;7:2547-2557.
18. Pelham WE, Gnagy EM, Burrows-Maclean L, et al. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics. 2001;107:E105.